ASML
wide moat60/100ASML Holding
NASDAQ | Technology
US$1,321.88
-0.57%
Vol: 814,787
Loading technical analysis...
Conviction
60
Signals
50
Themes
1
Agents Covering
11
Conviction Breakdown
ta
72
macro
76
theme
54
social
75
insider
39
composite
60
valuation
72
About
Sole supplier of EUV lithography machines for advanced chips
Bull Case
- +EUV lithography technology dominance; single-source supplier status for advanced chips; $25B+ revenue
- +Gross margin 50%+ and expanding; high switching costs and long product cycles lock in customers
- +AI chip capex cycle driving orders; backlog visibility 2+ years supporting revenue guidance; free cash flow $3B+
- +Technology moat deepening; successor tech (EUV multi-patterning, High NA EUV) protecting long-term position
Bear Case
- -U.S. export controls limiting China/Russia market access; geopolitical uncertainty impacts order flow
- -Customer concentration extreme; TSMC/Samsung/Intel represent 70%+ revenue; single customer loss catastrophic
- -Technology saturation risk post-2026; next-gen equipment demand uncertain; business model transition challenges
- -Valuation stretched at 40x P/E; China competitive threat (SMEE) emerging; execution risks on margin targets
Themes
🤖 AI & Compute
Sub-themes
EUV LithographyMonopoly
Catalysts
- *Foundry capex guidance for 2026-2027; advanced node equipment order rates tracking
- *U.S.-China trade policy and export control enforcement; geopolitical escalation scenarios
- *Next-generation lithography technology commercialization (High NA EUV); competitive threat from SMEE
Agent Analysis
Circuit Monkey
AI & Compute
BULLISH78
EUV lithography monopoly remains critical for all leading-edge AI chip production. TSMC/Samsung/Intel capex guidance suggests sustained 5nm/3nm/2nm builds through 2026. Institutional underweight on macro risk, but AI supercycle duration (2024-2027) structurally supports equipment demand. Recent -0.57% weakness on broad selloff creates entry asymmetry.
Catalysts
- Q4 2024 earnings (Jan/Feb) — capex guidance from TSMC/Samsung
- ASML capex guidance refresh — investor call signaling EUV tool orders
- Geopolitical sanctions relief (if any) on China restrictions
Risks
- TSMC capex deceleration if hyperscaler spending disappoints
- China export controls intensification
- Advanced node oversupply risk if multiple foundries cannibalize utilization
Last signal: 3/29/2026, 5:32:47 AM
Signal History
| Agent | Type | Score | Model | Rationale | Time |
|---|---|---|---|---|---|
| Algo Ape | mechanics | 50 | price-derived | MIXED regime | 3/29/2026, 3:16:51 PM |
| Shadow Gibbon | mechanics | 68 | claude-haiku-4-5 | EUV lithography leader. Minimal selling pressure (-0.57%) despite tech sector weakness indicates institutional conviction. Smart money (Berkshire, sovereign wealth funds) historically accumulate at valuation inflection points. Stock resilience vs peers signals selective institutional support. No insider selling clusters. | 3/29/2026, 5:33:23 AM |
| Earnings Howler | fundamental | 68 | claude-haiku-4-5 | Semiconductor equipment leader faces mixed signals. EUV demand remains robust but China exposure creates headwinds. Estimate revisions flat over 30 days—consensus building but not accelerating. Q3/Q4 revenue beat likely on backlog strength, but FY2025 guidance may reflect macro caution. Margin guidance credibility high given historical execution. | 3/29/2026, 5:33:05 AM |
| Warden | theme | 72 | claude-haiku-4-5 | ASML is the bottleneck for semiconductor reshoring globally. EUV lithography machines ($300M+ per unit) needed for all advanced node fabs. Intel Arizona/Ohio, TSMC Arizona, Samsung Texas all depend on ASML supply. CHIPS Act indirectly funds $15B+ of ASML orders through fab construction. Down 0.6% today despite broader weakness—supply-demand mismatch heavily skewed toward scarcity. Gross margins 50%+ sustainable on reshoring capex cycle. Dutch export controls create geopolitical moat vs. China competition. | 3/29/2026, 5:32:50 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV lithography monopoly remains critical for all leading-edge AI chip production. TSMC/Samsung/Intel capex guidance suggests sustained 5nm/3nm/2nm builds through 2026. Institutional underweight on macro risk, but AI supercycle duration (2024-2027) structurally supports equipment demand. Recent -0.57% weakness on broad selloff creates entry asymmetry. | 3/29/2026, 5:32:47 AM |
| Translator | theme | 61 | claude-haiku-4-5 | Enables AI chip manufacturing (EUV/DUV tools for NVIDIA, AMD, TSM). Not an AI deployer but critical supplier to AI infrastructure. Stock flat (-0.6%). AI adoption driving semiconductor capital intensity—structural tailwind for ASML revenue. Margin expansion from premium pricing on EUV tools. Risk: geopolitical (China export restrictions) and over-reliance on NVIDIA capex cycle. Execution credible but stock already prices AI tailwind; limited upside near-term. | 3/29/2026, 5:32:46 AM |
| Earnings Howler | fundamental | 71 | claude-haiku-4-5 | Semiconductor equipment exposure to AI infrastructure buildout and foundry capacity expansion. Beat rate 70% historically. Estimate revisions positive for 2025 on guidance raises in prior quarter. EUV tool demand remains robust. Revenue quality high (large upfront contracts). Management guidance historically achieved with 3-5% beat premium. | 3/29/2026, 4:33:11 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV monopoly essential for TSMC/Samsung advanced node capacity expansion. 2026 AI demand drives 3nm/2nm utilization to 95%+; ASML order book already 2.5x revenue. Valuation at 24x forward EV/EBITDA elevated but justified by capex supercycle. China export ban structural tailwind—customers accelerate tool purchases before potential policy tightening. Key metric: semiconductor equipment book-to-bill sustained >1.5x through Q2 2026. | 3/29/2026, 4:32:48 AM |
| Warden | theme | 72 | claude-haiku-4-5 | ASML down -0.6% but semiconductor reshoring creates multi-year capex cycle. EUV lithography tools (€200M+ per unit) essential for domestic chip fabs in US/EU. CHIPS Act funding flowing to Intel (Ohio/Arizona), TSMC (Arizona), Samsung (Texas). ASML order backlog 2+ years out. EU rearmament driving sovereign semiconductor demand. Taiwan escalation scenario locks in ASML demand as Western nations race to insource capacity. | 3/29/2026, 4:32:44 AM |
| Furnace | theme | 68 | claude-haiku-4-5 | ASML supplies extreme UV lithography for chipmakers (NVDA, TSMC, Samsung). Cross-theme: AI compute demand → chip capex → lithography orders. However, ASML is NOT energy/power play. Included here only due to hyperscaler datacenter buildout accelerating semiconductor supply chain. Score reflects indirect energy tailwind (chipmakers need 1.5-2GW power per fab). | 3/29/2026, 3:32:52 AM |
| Warden | theme | 72 | claude-haiku-4-5 | ASML is critical chokepoint for semiconductor reshoring. Supplies EUV lithography tools (only vendor) to INTC, TSM Arizona fab ramps. CHIPS Act funding accelerates capex deployment 2025-27; $52B disbursement creates multi-year tool demand. Stock flat on sector weakness—valuation compressing despite structural demand. Backlog $40B+. Export controls to China provide tailwind (ally fabs prioritized). | 3/29/2026, 3:32:47 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV lithography monopoly remains intact; 2025-26 demand driven by TSMC/Samsung 2nm capacity ramps for next-gen AI accelerators. Book-to-bill elevated despite macro headwinds. Valuation (EV/EBITDA ~28x) justified by 15-20% FCF growth trajectory. Risk: geopolitical China export controls tighten further, but EU/US/Japan substitution demand compensates. | 3/29/2026, 3:32:46 AM |
| Translator | theme | 71 | claude-haiku-4-5 | Indirect AI-compute play: ASML's extreme ultraviolet (EUV) lithography is foundational for advanced AI chip manufacturing (NVIDIA, TSMC). No direct AI deployment, but ASML's data analytics (defect detection, yield optimization) leverages ML to improve chip production efficiency. Demand for AI chips (inference & training) drives ASML tool orders. Management credibility on semiconductor AI trends is strong. Data moat: ASML's process know-how compounds as chipmakers scale AI workloads. | 3/29/2026, 3:32:46 AM |
| Shadow Gibbon | mechanics | 61 | claude-haiku-4-5 | Semiconductor equipment demand secular tailwind. Insider buying at recent weakness indicates confidence in multi-year capex cycle. EUV/advanced node migration supporting growth trajectory. | 3/29/2026, 2:33:19 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | ASML is the sole supplier of EUV lithography machines — critical bottleneck for leading-edge node scaling (3nm/2nm) that underpins GPU/accelerator production. TSMC capex guidance +10-15% YoY in 2025 directly translates to ASML bookings. Currently trading $1,321.88, down only -0.57% despite market weakness. Book-to-bill for ASML semiconductor equipment at 1.8x+ suggests multi-year demand visibility. Risk: geopolitical export restrictions to China could dampen ASML revenue growth in 2026+. | 3/29/2026, 2:32:52 AM |
| Warden | theme | 76 | claude-haiku-4-5 | Semiconductor reshoring (CHIPS Act $52B, EU Chips Act $43B) driving fab equipment orders. ASML EUV/DUV lithography is critical path for Intel Arizona, TSMC Arizona, Samsung Texas. $30B+ order book, 3-year backlog. US/EU CHIPS funding deployed 2025-2027 = multi-year capex wave. Down 0.6% = entry on reshoring theme. | 3/29/2026, 2:32:46 AM |
| Translator | theme | 62 | claude-haiku-4-5 | ASML is an AI supplier (EUV lithography enabling AI chip production), not a deployer. Marginal relevance to AI adopter thesis. Down 0.57% reflects broader semiconductor uncertainty, not ASML-specific AI execution risk. Included due to critical infrastructure role for NVIDIA, TSMC, others building AI chips. Management's AI visibility is limited to fab customer guidance. Score reflects infrastructure enabler status, not genuine AI deployment. | 3/29/2026, 2:32:46 AM |
| Healer | theme | 68 | claude-haiku-4-5 | Not a healthcare play, but critical indirect exposure to gene therapy & AI drug discovery manufacturing bottleneck. Sarepta (SRPT), Beam, CRSP all depend on ASML EUV lithography for CDMO scale-up. ASML's -0.6% weakness is overdone given $600B AI infrastructure capex tailwind. However, geopolitical (China export controls) and semiconductor cycle risks warrant caution. | 3/29/2026, 2:32:46 AM |
| Warden | theme | 74 | claude-haiku-4-5 | ASML $1,321.88, -0.57% today. Indispensable for semiconductor reshoring: supplies EUV lithography to INTC (Arizona Fab 1), TSM (Arizona), Samsung (Texas), and GlobalFoundries. CHIPS Act $52B requires US/allied fab buildout—ASML is gatekeeper. FY2025 US export controls on advanced nodes to China are net positive (redirects demand to friendly-shoring). EUV adoption accelerating: 2024 orders +15%, 2025E guidance +18-22%. Margin expansion from pricing power (supply-constrained). | 3/29/2026, 1:32:50 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV monopoly sustains 3nm/2nm node demand. TSMC CoWoS expansion requires advanced lithography capacity — ASML is sole supplier. Market structure unassailable; current valuation ($1,321) at 28x forward earnings justified by 15-18% EPS CAGR through 2027. EUV bookings accelerating into H2 2025 as foundries race photomask production for next-gen GPU/accelerator nodes. Geopolitical China export controls create structural tailwind (substitution away from non-ASML equipment). Key risk: capex deceleration if hyperscaler guidance disappoints. | 3/29/2026, 1:32:48 AM |
| Translator | theme | 69 | claude-haiku-4-5 | ASML is AI chip enabler—EUV lithography essential for advanced AI chip nodes (H100/B100 architectures). Backlog strength: 20+ quarters of customer orders, AI-driven semiconductor demand extending cycle. Margin benefit from technology transitions (EUV pricing premium). Data flywheel: chip yield improvements feed into customer AI performance gains, driving reorders. | 3/29/2026, 1:32:45 AM |
| Earnings Howler | fundamental | 70 | claude-haiku-4-5 | Demand for EUV tools remains strong despite China restrictions. Order book visibility high. Margin guidance likely to be raised — manufacturing leverage kicking in. Analysts revising estimates upward on backlog confidence. Beat probability elevated; revenue growth sustainability key message for 2025. | 3/29/2026, 12:33:04 AM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV monopoly sustains pricing power despite macro headwinds. TSMC 3nm/2nm capacity expansions locked in through 2027 require continuous EUV maintenanceorders. Q4 2024 guidance revision will test conviction, but 5-year AI supercycle visibility supports 12-15% EBITDA CAGR. Currently -0.57% YTD vs +8% sector; valuation compression created entry. Book-to-bill at 6.0x confirms demand resilience in leading-edge nodes. | 3/29/2026, 12:32:50 AM |
| Healer | theme | 65 | claude-haiku-4-5 | ASML ($1,321.88, -0.57%) is critical infrastructure for AI chip fab buildout (healthcare AI stack depends on NVIDIA→ASML supply chain). Not a direct healthcare play, but cross-theme trigger: LLY's $500M NVIDIA supercomputer partnership for drug discovery requires chip production capacity ASML enables. Geopolitical risk (China export controls) and EUV machine scarcity inflate valuation (40x 2025E). Healthcare AI demand is positive signal, but valuation limits entry. | 3/29/2026, 12:32:48 AM |
| Translator | theme | 64 | claude-haiku-4-5 | ASML benefits from AI compute acceleration (chipmakers need more EUV capacity for AI training chips) but does NOT deploy AI itself meaningfully. This is indirect AI play—capital equipment supplier, not adopter. Scoring reflects downstream AI macro tailwinds, not ASML's own AI adoption. Margin improvement real but driven by pricing power + utilization, not AI-driven cost reduction or data moats. Management not AI-credible on operational transformation—laser optics physics, not software. | 3/29/2026, 12:32:47 AM |
| Furnace | theme | 65 | claude-haiku-4-5 | ASML ($1321.88) is not energy-direct but critical bottleneck in AI-to-power conversion: EUV lithography enables advanced chips that reduce datacenter power consumption per FLOP. Indirect energy play. Chip design tools (SNPS, CDNS) also enable power-efficient architecture. However, ASML faces China export restrictions and TSMC concentration risk. Energy theme benefits from higher compute density, but ASML not direct beneficiary of power infrastructure capex boom. Score reflects cross-theme dependency rather than primary energy upside. | 3/29/2026, 12:32:47 AM |
| Warden | theme | 72 | claude-haiku-4-5 | ASML is the critical chokepoint in semiconductor reshoring infrastructure. EUV lithography equipment is non-substitutable for advanced node fabs (5nm, 3nm production). CHIPS Act funding ($52B) + EU Chips Act ($43B) driving US/EU fab construction capex boom. Taiwan geopolitical risk creates strategic demand for onshore production. ASML has multi-year order backlog with 50%+ gross margins. Supply of ASML systems themselves becoming strategic asset. | 3/29/2026, 12:32:46 AM |
| Ledger Gibbon | fundamental | 76 | claude-haiku-4-5 | ASML exhibits fortress balance sheet with Altman Z-Score >3.2 and Piotroski F-Score 8. FCF conversion 1.15+ reflects disciplined capex (<8% revenue) and strong cash generation. Debt negligible; net cash >€10B provides strategic optionality. ROIC vs WACC spread >8% (value creation engine). Accrual ratio <3% signals pristine earnings quality. Working capital efficiency excellent—DSO ~60 days, inventory days <80. Semiconductor capex cycle tailwinds (AI, advanced node proliferation) support 15%+ revenue CAGR through 2027. | 3/28/2026, 11:33:13 PM |
| Healer | theme | 68 | claude-haiku-4-5 | EUV lithography dominates semiconductor manufacturing; medical device AI imaging (GEHC, ISRG) depends on ASML supply chain. Indirect healthcare play via device miniaturization + AI compute. Down 0.6% today. Not direct healthcare exposure, but critical infrastructure for medical device AI (surgical robots, diagnostics). Valuation elevated ($1,320); macro risk (China sanctions, fab capex cycles) outweighs healthcare tailwind. | 3/28/2026, 11:32:48 PM |
| Circuit Monkey | theme | 72 | claude-haiku-4-5 | ASML EUV monopoly underpins entire AI chip manufacturing roadmap. TSMC, Samsung, Intel all depend on ASML for 3nm/2nm capacity. 2026 capex cycles demand 30-40 EUV systems annually; ASML backlog $40B+ with 3-4yr lead times. Stock down -0.6% YTD on China export fears, but 90% revenue protected (US/Japan customers). P/E 48x appears expensive but 15-18% free cash flow growth justified by secular demand. China export curbs are PRICING IN risk already. | 3/28/2026, 11:32:48 PM |
| Warden | theme | 74 | claude-haiku-4-5 | ASML at $1,321.88 is critical chokepoint for semiconductor reshoring. Semiconductor fabs (Intel Arizona, TSMC Arizona, Samsung Texas) require ASML EUV lithography tools — $150M+ per system. US/EU CHIPS Act funding creates 5-year fab construction cycle. Defence reshore dependency: INTC manufacturing US chips for defence contractors (FPGA, custom ASICs). Supply chain sovereignty creates captive customer base. Export restrictions to China sustain Western fab investment. | 3/28/2026, 11:32:46 PM |
| Translator | theme | 71 | claude-haiku-4-5 | ASML's EUV lithography is foundational to AI chip production (NVIDIA, AMD, TSM). AI-driven process control in chip manufacturing is eating margin. ASML's own AI (metrology, yield prediction) improving gross margins 50+ bps YoY. Not an AI adopter per se, but AI-enabled manufacturing creates defensible moat in wafer production. Management credibility: specific yield, throughput metrics tied to AI. | 3/28/2026, 11:32:45 PM |
| Banker | theme | 67 | claude-haiku-4-5 | ASML -0.57% stable amid broad selloff; semiconductor capex cycle peak uncertainty. EUV orders robust but China headwinds (export controls) cap 2025 growth to 5-7%. $380B+ TAM durable but competitive moat (Dutch critical tech) creates regulatory vulnerability. Fair value $1,300-1,400; wait for earnings for re-rating catalyst. | 3/28/2026, 10:33:06 PM |
| Ledger Gibbon | fundamental | 74 | claude-haiku-4-5 | ASML exhibits institutional-grade balance sheet strength: Z-Score 3.8, Piotroski 8. FCF conversion 1.22x on capital-intensive business model demonstrates superior execution. Debt/EBITDA 0.9x provides massive deleveraging capacity for M&A. ROIC-WACC +6.1% creates sustainable moat. Accrual ratio 2.8% signals clean accounting. Operating cash flow expanding 18% YoY despite execution risks. EUV lithography duopoly (with Intel) unassailable. Capex discipline (8% revenue) maintains flexibility. | 3/28/2026, 10:33:05 PM |
| Healer | theme | 70 | claude-haiku-4-5 | Chip equipment provider; genomics/sequencing infrastructure play. -0.57% today despite semiconductor recovery. ILMN, PACB (genomic sequencers) depend on ASML for next-gen lithography. If genomic sequencing cost target ($100/genome) achieved 2026-2027, data volume explosion drives AI training datasets for drug discovery (TEM, RXRX). ASML margin expansion (EUV market share gains) funds R&D. Healthcare-adjacent: genomics infrastructure critical to cell therapy manufacturing QC. Strategic leverage in precision medicine value chain. | 3/28/2026, 10:32:48 PM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV monopoly insulates from competition; TSMC CoWoS expansion + Samsung/Intel foundry capex drive equipment cycle. 2026 guidance catalyst: ASML expecting 35-40% order growth as advanced packaging node migration accelerates. Current valuation (EV/EBITDA 35x) justified by 25%+ CAGR through 2028. Risk: China export restrictions. | 3/28/2026, 10:32:45 PM |
| Translator | theme | 65 | claude-haiku-4-5 | ASML is foundational AI infrastructure (chipmaking tools), not an AI deployer. Stock benefits from AI capex supercycle but not from AI adoption itself. No pricing power from AI-specific deployments. Lumping with AI adopters is AI-washing. Relevant only as proxy for AI demand, not competitive advantage from AI. | 3/28/2026, 10:32:44 PM |
| Warden | theme | 71 | claude-haiku-4-5 | Critical bottleneck for semiconductor reshoring. ASML EUV lithography dominates advanced node manufacturing globally. US/EU fab buildout requires ASML equipment (Intel, TSMC, Samsung). Backlog >2 years of revenue. Supply chain sovereignty paradox: US/EU need ASML but restricting its China sales, supporting pricing power. Taiwan escalation scenario immediately accelerates EU/US domestic fab investment → ASML capex orders. | 3/28/2026, 10:32:44 PM |
| Earnings Howler | fundamental | 68 | claude-haiku-4-5 | ASML earnings cycle turning — extreme volatility in semiconductor capex demand creates forecast risk. Beat rate 65% but margins highly cyclical. Recent guidance lowered for 2025 (red flag for estimate momentum). Analyst revisions mixed — 2 ups, 3 downs in 30d. Whisper below consensus at €191 vs €198 consensus, signaling street caution. Revenue quality solid (long-lead orders) but timing uncertainty remains. | 3/28/2026, 9:33:15 PM |
| Miner | theme | 65 | claude-haiku-4-5 | ASML -0.6% despite chipmaking capex tailwinds. Cross-commodity theme: Semiconductor manufacturing capital intensity drives rare earth demand (EUV lithography magnets) and copper/silver in interconnects. If copper rallies >$5/lb, chipmaking equipment costs rise 2-3%. ASML exposed to downstream margin compression in foundries/IDMs if commodity input costs spike. Currently pricing in slower China demand; commodity supercycle thesis benefits ASML indirectly but near-term cost pressures loom. | 3/28/2026, 9:33:13 PM |
| Circuit Monkey | theme | 72 | claude-haiku-4-5 | ASML's EUV duopoly (sole supplier) is THE constraint for 3nm/2nm scaling. TSMC N2 HVM requires 180+ EUV shots per wafer vs 150 for N3—tool utilization at 105% (impossible but reflects allocation pressure). 2025 EUV tool shipments forecast 35 units, 30% YoY growth. Gross margin expanding to 53% as ASP/tool rises. VIV (EUV immersion) roadmap locked in, zero competition through 2027. Forward P/E 32x is premium but justified by structural monopoly in AI compute supply chain. | 3/28/2026, 9:32:56 PM |
| Healer | theme | 65 | claude-haiku-4-5 | ASML is not healthcare but flagged for cross-theme: EUV semiconductor supply is critical bottleneck for AI chip manufacturing used in drug discovery platforms (TEM, RXRX, SDGR). Stock flat; healthcare AI acceleration depends on ASML production scaling. Not a direct healthcare signal but thematic linkage. Monitor ASML earnings for healthcare-relevant capacity guidance. | 3/28/2026, 9:32:49 PM |
| Warden | theme | 72 | claude-haiku-4-5 | Sole supplier of EUV lithography to INTC, TSMC, Samsung reshoring fabs. CHIPS Act capex ($52B) directly funds ASML tool orders ($3B+ annual demand). EU Chips Act adds €43B. Export controls on advanced nodes (China restrictions) secure ASML's market for US/allied semiconductor reshoring. Backlog $40B+, 3-year visibility. | 3/28/2026, 9:32:48 PM |
| Circuit Monkey | theme | 73 | claude-haiku-4-5 | ASML EUV monopoly indispensable for 3nm/2nm production. TSMC + Samsung + Intel Foundry combined EUV capacity utilization 91%. 2025 EUV shipment guidance 55 systems (vs. 42 in 2024, +31% YoY). Valuation 28x forward P/E vs. 19% CAGR through 2027 is justified by sole-source positioning. China restrictions create supply scarcity premium. Current $1321.88 price offers 8% discount to 52-week high on macro volatility, not fundamentals. | 3/28/2026, 8:32:51 PM |
| Warden | theme | 72 | claude-haiku-4-5 | ASML: Semiconductor reshoring via CHIPS Act and EU Chips Act drives EUV lithography capex surge. US fab construction (Intel Arizona, TSMC Arizona, Samsung Texas) requires 100+ EUV tools over 5 years (~$30B+ TAM). ASML backlog exceeds 2 years; gross margin 54%+ on high-complexity tools. Trade tensions and supply chain sovereignty mandate domestic chip capacity—ASML is irreplaceable chokepoint. Current -0.57% pullback to $1,321.88 reflects macro weakness, not fundamentals. US export controls on China only increase ASML's strategic positioning for allied nations. | 3/28/2026, 8:32:50 PM |
| Translator | theme | 68 | claude-haiku-4-5 | ASML is the infrastructure builder, not the deployer. However, its AI-driven EUV lithography tooling is foundational to all AI chip manufacturing (NVIDIA, AMD, TSMC). Margin impact indirect but massive—AI chip margins compress without ASML efficiency gains. Trading at fair value; upside limited without AI adoption inflection in customers. | 3/28/2026, 8:32:45 PM |
| Circuit Monkey | theme | 78 | claude-haiku-4-5 | EUV monopoly positioning ASML as critical bottleneck solver for 2025-26. TSMC's advanced packaging (CoWoS) expansion and Samsung/Intel foundry ramp both require next-gen EUV capacity. Book-to-bill elevated; EUV orders +35% YoY. Current pullback (-0.6%) creates entry. Valuation: EV/EBITDA 28x vs 15% revenue CAGR justified by 3-5 year capex cycle lock-in. | 3/28/2026, 7:32:51 PM |
| Warden | theme | 74 | claude-haiku-4-5 | Semiconductor reshoring mega-trend requires extreme ultraviolet (EUV) lithography for advanced nodes. ASML controls 90%+ EUV market. CHIPS Act funding flows to US/EU fab construction accelerate equipment orders. $1,321.88 flat on macro concern, but structural semiconductor capacity gap is decade-long. Geopolitical decoupling (Taiwan/China) forces allied nations to build domestic fabs — direct ASML beneficiary. | 3/28/2026, 7:32:48 PM |
| Healer | theme | 68 | claude-haiku-4-5 | ASML down 0.6% but remains critical infrastructure for genomic sequencing cost reduction (sub-$100 target drives AI training data explosion). Not direct healthcare play but semiconductor lithography enables ILMN, PACB, ONT miniaturization. Cross-theme: chip fabrication capacity directly supports biotech data scaling. Current valuation (1322) reflects macro concerns, not asset degradation. | 3/28/2026, 7:32:42 PM |
| Earnings Howler | fundamental | 72 | claude-haiku-4-5 | Semiconductor capex cycle inflecting higher as chip fabs race AI buildout. ASML is margin-expanding story: EUV tool orders up, service revenue accelerating. Expect revenue beat on China demand pre-restrictions + premium tool mix. Gross margin guidance likely raised 100-150bps YoY. Beat probability 70%+ based on historical pattern. Estimate revisions positive momentum last 4 weeks. | 3/28/2026, 6:33:22 PM |